GRASSI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 2.564
AS - Asia 1.685
EU - Europa 1.003
SA - Sud America 438
AF - Africa 94
Continente sconosciuto - Info sul continente non disponibili 72
OC - Oceania 27
Totale 5.883
Nazione #
US - Stati Uniti d'America 2.431
SG - Singapore 566
BR - Brasile 361
CN - Cina 313
IT - Italia 246
HK - Hong Kong 202
FI - Finlandia 184
VN - Vietnam 136
BD - Bangladesh 123
RU - Federazione Russa 93
DE - Germania 90
GB - Regno Unito 85
ID - Indonesia 78
FR - Francia 74
CA - Canada 65
TR - Turchia 54
IN - India 50
NL - Olanda 49
UA - Ucraina 35
MX - Messico 29
ES - Italia 28
AR - Argentina 27
AU - Australia 25
ZA - Sudafrica 25
MA - Marocco 20
PK - Pakistan 20
SA - Arabia Saudita 20
JP - Giappone 17
AT - Austria 16
IE - Irlanda 16
PH - Filippine 16
IQ - Iraq 15
NG - Nigeria 15
SE - Svezia 15
KR - Corea 13
CO - Colombia 12
EC - Ecuador 12
PL - Polonia 12
CZ - Repubblica Ceca 11
KE - Kenya 10
PT - Portogallo 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 8
JO - Giordania 8
NI - Nicaragua 8
CR - Costa Rica 6
DZ - Algeria 6
EG - Egitto 6
BE - Belgio 5
HN - Honduras 5
JM - Giamaica 5
RO - Romania 5
TH - Thailandia 5
UZ - Uzbekistan 5
AL - Albania 4
GT - Guatemala 4
HU - Ungheria 4
LU - Lussemburgo 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
TW - Taiwan 4
GE - Georgia 3
GR - Grecia 3
IL - Israele 3
KZ - Kazakistan 3
TL - Timor Orientale 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
HT - Haiti 2
LB - Libano 2
LI - Liechtenstein 2
LT - Lituania 2
LY - Libia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GF - Guiana Francese 1
GH - Ghana 1
Totale 5.802
Città #
Singapore 274
Ashburn 186
Hong Kong 172
Helsinki 160
Los Angeles 118
Council Bluffs 117
Chicago 113
San Jose 113
New York 103
The Dalles 99
Beijing 85
Columbus 58
Buffalo 56
Chandler 54
Ho Chi Minh City 49
Dallas 47
Lauterbourg 46
Salt Lake City 46
Milan 41
Santa Clara 38
Tampa 36
Fairfield 35
Hanoi 32
Wilmington 29
Seattle 28
Houston 26
Istanbul 26
São Paulo 25
Elk Grove Village 24
Jakarta 24
Princeton 24
Sterling 23
Moscow 22
Amsterdam 21
Des Moines 21
Munich 21
Nuremberg 21
San Francisco 21
Atlanta 20
Toronto 20
Montreal 18
Redondo Beach 18
Woodbridge 18
Brescia 17
Rio de Janeiro 17
Lappeenranta 16
Dublin 15
Phoenix 15
Rome 15
Shanghai 15
Lancaster 14
Tokyo 14
Boardman 13
Bologna 13
Cambridge 13
Jacksonville 13
Nashville 13
Sydney 13
Warsaw 12
London 11
Naples 11
Denver 10
Las Vegas 10
Nairobi 10
Orem 10
Stockholm 10
Brooklyn 9
Kyiv 9
Mexico City 9
Mountain View 9
Mumbai 9
New Delhi 9
Abuja 8
Amman 8
Ann Arbor 8
Coventry 8
Detroit 8
Fes 8
Florence 8
Lisbon 8
Managua 8
Miami 8
San Diego 8
Abha 7
Brno 7
Frankfurt am Main 7
Romola 7
Vienna 7
Bandung 6
Bari 6
Charlotte 6
Chennai 6
Da Nang 6
Dhaka 6
Dulles 6
Guayaquil 6
Johannesburg 6
Manchester 6
Paris 6
Porto Alegre 6
Totale 3.077
Nome #
2023 ESH Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) 1.188
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 571
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension 235
Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA) 189
Serum Uric Acid/Serum Creatinine Ratio and Cardiovascular Mortality in Diabetic Individuals—The Uric Acid Right for Heart Health (URRAH) Project 145
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 144
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension 142
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality over 20 Years 141
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension 126
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines 111
Determinants of healing among patients with COVID-2019: the results of the SARS-RAS study of the Italian Society of Hypertension 111
Accuracy of home blood pressure measurement: the ACCURAPRESS study–a proposal of Young Investigator Group of the Italian Hypertension Society (Società Italiana dell’Ipertensione Arteriosa) 110
Telemedicine and Digital Medicine in the Clinical Management of Hypertension and Hypertension-Related Cardiovascular Diseases: A Position Paper of the Italian Society of Arterial Hypertension (SIIA) 109
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 106
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension 100
Mechanisms of Vascular Inflammation and Potential Therapeutic Targets: A Position Paper From the ESH Working Group on Small Arteries 98
SERUM URIC ACID PREDICTS HEART FAILURE IN A LARGE ITALIAN COHORT. SEARCH FOR A CUT-OFF VALUE The URRAH (URic acid Right for heArt Health) study 86
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional-Based Italian Database 85
Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level 85
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 84
Juxtaposing Hypertension Guidelines: Are They Different? A Pragmatic Look to ESC and ESH Guidelines on (Arterial) Hypertension 83
Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern 81
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 80
Italian Society of Interventional Cardiology (GISE) and Italian Society of Arterial Hypertension (SIIA) Consensus document on the role of renal denervation in the management of the difficult to treat hypertension 79
Practical Guidelines for Patients with Hypertension and Periodontitis 78
Prevalence of Cardiovascular Risk Factors and Related Medical and Lifestyle Interventions Among Italian Cardiovascular Specialists: A Proof-of-Concept Study 74
Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study 73
Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study 71
Home oral hygiene is associated with blood pressure profiles: Results of a nationwide survey in Italian pharmacies 71
Machine Learning in Hypertension Detection: A Study on World Hypertension Day Data 70
The UrgeRe (Urgenze Ipertensive: Un Progetto Educazionale Fondato Sulla Vita Reale, Hypertensive Urgencies: A Project in the Real World) Project 66
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk 64
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines 61
Erratum: Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARSRAS study of the Italian Society of Hypertension (PLoS ONE (2020) 15:10 (e0237297) DOI: 10.1371/journal.pone.0237297) 61
Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy 58
Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values 57
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 57
Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension 56
Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient 56
Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) project 54
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney 50
The importance of microvascular inflammation in ageing and age-related diseases: a position paper from the ESH working group on small arteries, section of microvascular inflammation 49
Serumuric acid, predicts heart failure in a large Italian cohort: Search for a cut-off value the URic acid Right for heArt Health study 46
Prevalence, Clustering, and Current Management of Cardiovascular Risk Factors Upon First Referral to Hypertension Specialists: the APPROACH Study 45
Real-World Hypertension Prevalence, Awareness, Treatment, and Control in Adult Diabetic Individuals: An Italian Nationwide Epidemiological Survey 45
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation 43
Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project 43
The 2023 hypertension guidelines of the European Society of Hypertension: a commentary 41
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional-Based Italian Database 38
Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients 38
Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project 32
Diagnostic and therapeutic approach to acute blood pressure elevations: results of an international survey among excellence centres of the European society of hypertension 29
Rationale for the Use of Fixed Combination Therapies with Angiotensin Converting Enzyme Inhibitors and Beta-Blockers in Patients with Essential Hypertension and High Cardiovascular Risk: A Consensus Document from the Italian Society of Arterial Hypertension (Siia) and the Italian Society of Cardiovascular Prevention (SIPREC) 24
Reclassification of patients with normal blood pressure levels after 2024 European society of cardiology guidelines on hypertension 18
Rationale for the Use of Fixed Combination Therapies with Angiotensin Converting Enzyme Inhibitors and Beta-Blockers in Patients with Essential Hypertension and High Cardiovascular Risk: A Consensus Document from the Italian Society of Arterial Hypertension (Siia) and the Italian Society of Cardiovascular Prevention (SIPREC) 16
Prevalence, awareness, and control of cardiovascular risk factors among specialists in cardiovascular field: A survey 9
null 1
Totale 5.883
Categoria #
all - tutte 24.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202264 0 0 0 4 0 12 5 7 4 9 3 20
2022/2023114 12 2 1 11 14 30 0 14 20 1 7 2
2023/2024106 7 0 18 5 3 29 1 1 26 0 2 14
2024/20251.655 57 20 29 112 71 44 138 32 99 269 627 157
2025/20263.234 205 304 173 338 189 210 394 219 394 354 195 259
2026/2027547 278 170 99 0 0 0 0 0 0 0 0 0
Totale 5.883